Amended Current Report Filing (8-k/a)
July 23 2015 - 4:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K/A
(Amendment No. 1)
CURRENT
REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 2, 2015
NUVASIVE, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
000-50744 |
|
33-0768598 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
7475 Lusk Boulevard, San Diego, California 92121
(Address of principal executive offices) (Zip Code)
(858) 909-1800
(Registrants telephone number, including area code)
n/a
(Former name or
former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions (see General Instruction A.2. below):
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers. |
On July 6, 2015, NuVasive, Inc. (the Company) filed a Current Report on
Form 8-K in which it announced that the Board of Directors of the Company (the Board) had elected Daniel J. Wolterman as a director of the Company, effective July 2, 2015. At the time of his election, Mr. Wolterman was not
appointed to serve on a Board committee. The Company is filing this Form 8-K/A to report that on July 22, 2015, Mr. Wolterman was appointed to serve as a member of the Compensation Committee of the Board. As of July 22, 2015, the
members of the Compensation Committee were Jack R. Blair, Peter C. Farrell and Daniel J. Wolterman.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
NUVASIVE, INC. |
|
|
|
|
Date: July 23, 2015 |
|
|
|
By: |
|
/s/ Jason Hannon |
|
|
|
|
|
|
Jason Hannon Executive Vice President,
International & General Counsel |
Nuvasive (NASDAQ:NUVA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nuvasive (NASDAQ:NUVA)
Historical Stock Chart
From Apr 2023 to Apr 2024